Aarkstore Enterprise R&D Trends: Colorectal Cancer Market Research ...

Introduction

The 113 drug colorectal cancer (CRC) pipeline is dominated by target therapies. VEGFR remains the leading target for drug developers, but there are a growing number of novel targeting therapies as drug developers look to increase efficacy, reduce toxicity, and avoid direct competition. Identification of the correct molecular target will be key to ensuring that a novel drug is effective.

Features and benefits

* In-depth analysis of colorectal cancer pipeline ? development stage, therapeutic class, molecular targets, and changes in pipeline since 2006
* In-depth analysis of current comparator therapy ? target product profile, unmet needs, and innovative early-stage approaches
* In-depth analysis of clinical trial design ? patient selection, duration, clinical endpoints, and future developments in trial design
* The future of colorectal cancer treatment ? increasing use of biomarkers, new combination therapies and novel targeted therapies

Highlights

Targeted therapies dominate the colorectal cancer pipeline. However, developers will face strong competition from established therapies already on the market. The advancement in understanding of the molecular basis of colorectal cancer has exposed new targets, but companies must identify the correct ones to improve the chances of success.
Clinical trial design must demonstrate the clinical efficacy of novel therapies. The selection of correct patient populations, trial duration, and endpoints is becoming increasingly important in the era of target therapy development. The use of biomarkers in colorectal cancer is somewhat modest, but could prove important in drug development.

?

For more information please visit link:

http://www.aarkstore.com/reports/R-D-Trends-Colorectal-Cancer-147612.html

Neel

Aarkstore Enterprise

Phone:08149852585

Email:enquiry@aarkstore.com

URL:www.aarkstore.com

More Reports

Plains Exploration & Production Company Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Norwegian Energy Company ASA Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Enerplus Corporation Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Kinder Morgan Energy Partners, L.P. Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Abu Dhabi National Energy Company PJSC Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Painted Pony Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis ? Q4, 2010
Sahara Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis ? Q4, 2010
Leed Petroleum PLC Oil & Gas Exploration and Production Operations and Cost Analysis ? 2010
Imperial Oil Limited Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Evolution Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis ? 2010
Celtic Exploration Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
PTT Exploration and Production PCL Oil & Gas Exploration and Production Operations and Cost Analysis ? 2010
Culane Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Bankers Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
Hugoton Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis ? Q4, 2010
Petrodorado Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis ? 2010
Progress Energy Resources Corp. Oil & Gas Exploration and Production Operations and Cost Analysis ? Q1, 2011
?

Source: http://www.eastsidewriter.com/aarkstore-enterprise-rd-trends-colorectal-cancer-market-research/

caterpillar ge better homes and gardens groupon shannen doherty shannen doherty blush